USP Zdrowie acquires Multilac brand

…and rights, from Genexo Sp. z o.o. The acquisition will complement the company’s product portfolio and represents an important step in its long-term growth strategy, USP Zdrowie said in a statement. Multilac has been present on the Polish market for more than 10 years.

Sign up now to open the entire news item.

You are allowed to open only one news item from PMR websites.
  • 1E-mail
    (to send requested information)
  • 2Brief profile
    (required for new e-mails only)

 required fields

You must accept PMR’s Privacy Policy.